Skip to content

Saturday, December 13, 2025

Latest:

From symptoms to solutions: How new guidelines are changing UTI care in spinal cord injury patients
Research suggests that Alzheimer’s disease may develop through distinct biological pathways
Sweat vs. sweets: The workout math behind holiday treats
Researchers make strides toward preventing parenteral nutrition-associated liver disease
A new approach to treating overactive bladder

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

brittle bone disease

Targeting TGF-β for treatment of osteogenesis imperfecta

March 22, 2022 brittle bone disease, fresolimumab, osteogenesis imperfecta, Research, TGF-β, treatment

A monoclonal antibody therapy that neutralizes TGF-β produced promising results in a Phase 1 clinical trial.

andersson-dyke-featured-photo

Young author raises brittle bone disease awareness, receives prestigious award

August 8, 2016 Affiliates, Allison Mickey, Andersson Dyke, Awards and Honors, brittle bone disease, Dr. Brendan Lee, Genetics, molecular and human genetics, osteogenesis imperfecta, Osteogenesis Imperfecta Foundation, pediatrics, Texas Children's Hospital

When she was nine years old, Andersson Dyke, a cat lover, began imagining an idea for a story; the journey of an abandoned lion cub

From the Labs: Image of the Month

From the Labs: Human intestinal organoid

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951